DOISS 625

THE SUPER SYNERGY
DOISS 625/1000

Composition

  • DOISS 625 Amoxycillin 500mg + Clavulanic acid 125mg Tablets

Indications

  • Lower Respiratory Tract Infections
  • Upper Respiratory Tract Infections
  • Otitis Media
  • Sinusitis
  • Soft Skin Tissue Infections
  • Urinary Tract Infections

Description

  • Amoxicillin/clavulanate potassium is an antibacterial combination consisting of the semisynthetic antibiotic amoxicillin and the β-lactamase inhibitor, clavulanate potassium.
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin/clavulanate potassium should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

DOISS

THE SUPER SYNERGY
DOISS

Composition

  • Amoxycillin 200 mg+ Clavulanic acid 28.5 mg/ 5ml Dry Syrup

Indications

  • Otitis Media

Description

  • Amoxicillin/clavulanate potassium is an antibacterial combination consisting of the semisynthetic antibiotic amoxicillin and the β-lactamase inhibitor, clavulanate potassium.
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin/clavulanate potassium should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

DOISS HS

THE SUPER SYNERGY
Doiss HS

Composition

  • Amoxycillin 400 mg + Clavulanic Acid 57 mg / 5 ml Dry Syrup

Indications

  • Acute Otitis Media

Description

  • Gold standard in Acute Otitis Media
  • DOISS HS available in 60 ml international pack
  • Ensures complete therapy
Doxcepta-Cv
EDVABACT-P

Composition

  • Amoxycillin 400 mg + Clavulanic Acid 57 mg / 5 ml Dry Syrup

Indications

  • Community acquired Pneumonia

Description

  • Offers excellent clinical efficacy
  • Effective against persistent & recurrent RTI
  • Good safety & tolerability profile
Doxcepta-Cv
EDVABACT-P

Composition

  • Cefpodoxime Proxetil 200 mg + Clavulanic Acid 125 mg Tablets
  • Cefpodoxime Proxetil 100 mg + Clavulanic Acid 62.5 mg per 5ml Suspension

Indications

  • Acute otitis media
  • Pharyngitis/tonsillitis
  • Acute maxillary sinusitis
  • Community-acquired pneumonia
  • Acute bacterial exacerbations of chronic bronchitis
  • Acute, uncomplicated urethral and cervical gonorrhea
  • Acute, uncomplicated ano-rectal infections in women
  • Uncomplicated skin and skin structure infections
  • Uncomplicated urinary tract infections

Description

  • Cefpodoxime Proxetil is a oral third generation cephalosporin antibiotic with effectiveness against most Gram positive and Gram negative bacteria. The bactericidal activity of Cefpodoxime results from its inhibition of cell wall synthesis.
  • Clavulanic acid, a beta-lactamase inhibitor which reduces resistance and enhances the activity of Cefpodoxime Proxetil against bacteria.
EDVABACT-P
EDVABACT-P

Composition

  • Cefixime 200 mg + Ofloxacin 200 mg Tablets

Indications

  • Typhoid fever
  • Urinary tract infection

Description

  • Cefixime is a 3rd generation cephalosporin, the bactericidal action of cefixime results from inhibition of cell wall synthesis. Cefixime is stable in the presence of certain beta-lactamase enzymes. As a result, certain organisms resistant to penicillins and some cephalosporins due to the presence of beta-lactamases may be susceptible to cefixime.
  • Ofloxacin is a synthetic fluoroquinolone antibacterial agent which inhibits bacterial topoisomerase IV and DNA gyrase enzymes required for DNA replication, transcription, repair, transposition and recombination.
Doazit
EDVABACT-P

Composition

  • Azithromycin 500 mg

Indications

  • Upper Respiratory Tract Infection

Description

    Azithromycin binds to the 50s subunit of bacterial ribsome,

  • Inhibits the translation of mRNA
  • Inhibits protein synthesis
  • Prevents bacteria from growing